Previous close | 42.90 |
Open | 42.90 |
Bid | 57.60 |
Ask | 62.40 |
Strike | 160.00 |
Expiry date | 2024-07-19 |
Day's range | 42.90 - 42.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.